Skin cancer. Benefiting from CTLA-4 blockade--a genetic rationale
- PMID: 25488393
- DOI: 10.1038/nrclinonc.2014.217
Skin cancer. Benefiting from CTLA-4 blockade--a genetic rationale
Comment on
-
Genetic basis for clinical response to CTLA-4 blockade in melanoma.N Engl J Med. 2014 Dec 4;371(23):2189-2199. doi: 10.1056/NEJMoa1406498. Epub 2014 Nov 19. N Engl J Med. 2014. PMID: 25409260 Free PMC article.
References
-
- N Engl J Med. 2014 Dec 4;371(23 ):2189-99 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
